Chronic lymphopenia and neutropenia in a dog with large granular lymphocytic leukemia

Museux, K.; Turinelli, Vanessa; Rosenberg, Dan; Piñeiro, I. Rodríguez

doi:10.1111/vcp.12809

Cited by 4 publications

(3 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Review of previously reported cases reveals a mean age of 9 years (range 4-14) across 41 cases. 5,14,[16][17][18][19][20][21][22][23] Across these previous publications, a male to female ratio of 0.7:1 was identified in contrast to the current study where male dominance was identified.…”

Section: Discussioncontrasting

confidence: 69%

“…Across the previous canine case reports, anaemia was identified in 56% of cases, neutrophilia in 49% of cases, thrombocytopaenia in 25% of cases and neutropenia in 17% of cases (some cases exhibited more than one cytopaenia). 5,14,[16][17][18][19][20][21][22][23] In comparison with the current study, these previously reported cases exhibited anaemia at nearly three times the occurrence and thrombocytopaenia at nearly two times the occurrence, while the incidence of neutrophilia was similar.…”

Section: Discussionsupporting

confidence: 54%

“…In 9 dogs with multiple submissions, known survival times since initial diagnosis ranged from 5 to 54 months, with individual survival times of 5,20,25,32,35,36,38, 50 and 54 months. Eight of these cases had a phenotype consistent with human T-LGL (CD3+, CD4À, CD8+) while the case with 50 months survival had a phenotype of CD3+, CD4+, CD8+.…”

Section: Patient Characteristicsmentioning

confidence: 99%

See 2 more Smart Citations

Clinicopathologic and immunophenotypic features in dogs with presumptive large granular lymphocyte leukaemia

Jaensch¹,

Hayward²,

Boyd

2022

Aust Veterinary J

View full text Add to dashboard Cite

Large granular lymphocytic leukaemia (LGLL) has been described in a range of species but has been most commonly reported in humans and dogs. In both species, this neoplasia exhibits diversity in both phenotype and biological behaviour with phenotype only partially predicting behaviour. There is currently little knowledge of concurrent haematological and serum biochemistry features or concurrent occurrence of distinct neoplasia in canine LGLL cases. This study presents a canine case series and defines haematological parameters, novel serum biochemistry findings and phenotype of the large granular lymphocytes in an Australian case series. Neutrophilia was the most common haematological abnormality, identified in 43% of dogs, and 84% of dogs with biochemistry data available had elevated serum gamma-glutamyl transferase. Five of the 40 dogs in this study exhibited concurrent neoplasia during the period of the study, demonstrating this is a relatively common clinical outcome in canine LGLL cases. In agreement with previous canine and human studies, the most common LGLL phenotype in dogs is CD3+, CD4À and CD8+. Further work is needed to define the variables predictive of the biological behaviour of LGLL in dogs.

show abstract

Section: Discussioncontrasting

confidence: 69%

Section: Discussionsupporting

confidence: 54%

Section: Patient Characteristicsmentioning

confidence: 99%

See 1 more Smart Citation

Clinicopathologic and immunophenotypic features in dogs with presumptive large granular lymphocyte leukaemia

Jaensch¹,

Hayward²,

Boyd

2022

Aust Veterinary J

View full text Add to dashboard Cite

show abstract

Leukocytes

2024

Clinical Atlas of Small Animal Cytology and Hematology

View full text Add to dashboard Cite

Retrospective Study of T Cell Leukaemia (Large Granular Lymphocyte Variant) in Dogs Associated with Suspected Immune-Mediated Cytopaenia(s) in the Absence of Peripheral Lymphocytosis

Capasso¹,

Villers

Elliott³

et al. 2023

Animals

View full text Add to dashboard Cite

Canine chronic large granular lymphocyte (LGL) leukaemia is commonly characterised by moderate to marked lymphocytosis but not neutropaenia. In humans, LGL leukaemia is often associated with autoimmune disorders, including immune-mediated cytopaenias (mainly neutropaenia). This presentation is rare in dogs. The aim of this retrospective study was to describe the clinical characteristics, treatments, and outcomes of dogs with chronic LGL leukaemia with suspected immune-mediated cytopaenia. Six dogs with a median age of 4.5 years (range 2–8 years) were included in the study. The most common presenting signs were pyrexia and lethargy. All dogs had severe neutropaenia (median neutrophil count 0.07 × 109/L), three had thrombocytopaenia (median platelet count 66 × 109/L), and one had anaemia (HCT 0.32 L/L). In all dogs, bone marrow cytology revealed infiltration of granular T lymphocytes; PARR analysis confirmed clonality in four, and bone marrow flow cytometry identified CD3+ CD8+ neoplastic cells in two cases. All patients received systemic chemotherapy, and the cytopaenias resolved after 1–19 weeks. Two dogs were euthanised 133 and 322 days after diagnosis, two were lost to follow-up after 224 and 357 days, and two were alive at 546 and 721 days. A subset of LGL leukaemia in dogs is associated with immune-mediated cytopaenia and has a unique clinical presentation.

show abstract

Chronic lymphopenia and neutropenia in a dog with large granular lymphocytic leukemia

Cited by 4 publications

References 17 publications

Clinicopathologic and immunophenotypic features in dogs with presumptive large granular lymphocyte leukaemia

Clinicopathologic and immunophenotypic features in dogs with presumptive large granular lymphocyte leukaemia

Leukocytes

Retrospective Study of T Cell Leukaemia (Large Granular Lymphocyte Variant) in Dogs Associated with Suspected Immune-Mediated Cytopaenia(s) in the Absence of Peripheral Lymphocytosis

Contact Info

Product

Resources

About